Introduction
Acute lung injury (ALI) is acute hypoxia respiratory insufficiency or failure caused by diffused pulmonary interstitial and alveolar oedema of pulmonary capillary endothelial cells in serious infection, shock, trauma, burns and other non cardiac disease process [1] . Lipopolysaccharide (LPS), the outer membrane of composition of Gram negative bacteria can directly or indirectly damage alveolar epithelium and pulmonary vascular endothelial cells [1] , induce a series of lung tissue pathological physiological change, and then development as the ALI [2] . LPS may induce excessive activation of NF-毷 beta in lung tissue, participate in a variety of genes related to early body defense reaction, such as expression and regulation of cell factors, adhesion molecules, inflammation medium, in the development process of ALI [3] . Sevoflurane is a new type of inhalation anesthetics with characteristics of induced quickly and small excitant, has good blood dynamics stability, its pretreatment [4] and reprocessing effect research become clinical research hot spots in recent years. Research shows that sevoflurane pretreatment can reduce endotoxin induced acute lung injury, protect lung function [5] . Inhalation anesthetics post-processing may be a protective scheme for viscera from reperfusion injuries [6] .
Materials and methods

Experimental animal
Clean grade male SD rats were from Shanghai Weasleyg Experimental Animal Co., LTD.. 45 male SD rats of weight (272 依 15) g, were randomly divided into three groups, with Objective: To observe the effects of sevoflurane treatment on lung inflammation in rats with lipopoIysaccharide-induced acute lung injury (ALI). Methods: The rat model of ALI was established by intratracheal instillation of lipopolysaccharide (LPS). 45 infantile SD rats [body weight (272依15) g] were randomly divided into 3 groups (n=15): control group, LPS group, sevoflurane group. NS (1 mL/kg) was instillated in rats'airways of control group; LPS (5 mg/ kg) was instillated in rats'airways of LPS group. Sevoflurane group rats received sevoflurane (2.4%) inhalation for a hour after LPS was instillated in rats'airways. Six hours after NS or LPS instillation, all rats were exsanguinated. Lung tissues were examined by HE staining. Expressions of TNF-毩 and ICAM1 mRNA were detected by semiquantitative RT-PCR techniques. The protein level of TNF-毩 and ICAM1 were assessed by western blot techniques. Results: In LPS group the permeability of lung tissues increased, organizational structure severely damaged and the alveolar wall tumed thick, with interstitial edema and Europhiles infiltrated increasingly. The LPS group had higher mRNA expressions of TNF-毩 and ICAM1 than control group and sevoflurane group (P<0.05), and LPS group had higher protein level of TNF-毩 and ICAM1 than control group and sevoflurane group (P<0.05). Conclusions: Sevoflurane treatment can attenuate lung inflammation in rats with lipopolysaccharide-induced acute lung injury. 15 in each, (1) the control group: 0.9% NaCl + 0.9% NaCl; (2) the endotoxin (LPS) groups: 0.9% NaCl + LPS; (3) sevoflurane groups: 0.9% NaCl + LPS. Rats were moved to anesthesia box after 4 h since modeled, with sevoflurane inhalation (concentration 2.4%) for l h, during spontaneous breathing.
Animal model establishment
With reference to the Chin method [7] , 40 mg/kg of pentobarbital was injected to rats by intraperitoneal injection. After anesthesia, limbs were fixed with high cutting teeth on board. By neck shaving, the median incision skin was 1 cm long, blunt separation organization was conducted to exposure trachea, with reagent extraction by 1 mL syringe, grafted in 25-gauge needle to puncture trachea; LPS or NS to trachea was injected slowly (30 seconds) after bubble appeared, suture incisions was performed. All rate were then put back to the cage with food and water supply freely, using desk lamp to maintain the body temperature at 37.5 ℃.
Tissue samples collection
The rats were sacrificed after 6 h since injection of LPS or NS. Pathology observation was performed under HE staining. Total RNA and protein were extracted for mRNA and protein detection. Protein expression was determined by Westernblot method. Cracking cells was performed with cell cracking fluid (Cell Signaling Teehnology company, USA), supernatant fluid was exacted after centrifuging, and total protein was detected using G-250 staining (total protein 50 毺 g for Western blot test).
Methods
Histotomy
The lower lobe was processed with 10% formaldehyde solution, 70%-100% alcohol gradient dehydration, xylene processed for 2 times for embedding, Spliced the wax fixed with section at thickness of 5-8 毺 m, and then put sample in constant temperature box at 45 ℃.
HE staining
The paraffin was taken off by Xylene, then alcohol from high was daaded to low concentration, and finally distilled water was added for staining.
Detection pf mRNA of TNF-毩 and ICAM1 by RT-PCR
Total RNA of three groups was extracted with Trizol method for reverse transcription, using 毬 -actin as internal reference. Primer sequence wass: upstream:
5'-GCTCGTCGTCGACAACGGCTG-3',downstream: 5'-CAAACATGATCTGGGTCATCTTTTC-3', amplified fragment for 353 bp. Rats TNF alpha primer sequence: upstream 5'-TGAGCACAGAAAGCATGATC-3', downstream: 5'-CATCTGCTGGTACCACCAGTT-3', amplified fragment for 396 bp; ICAM1 primer: 5'-TTTTGGCTCGGAAGGTGG-3' upstream, downstream 5'-TGTCGGATTGGAAGTGGC-3', amplification product length 421 bp; Electrophoresis image was analyzed by using GelprO4 software, the average optical density value was set as representative density, on behalf of the corresponding amount of gene expression, and then divided by 毬 -actin average optical density value, the results standed for the amplification product relative mRNA expression quantity.
Detection of lung tissue TNF-毩 and ICAM1 by Western blot method
Western blot (5% gel) was carried out under 80 eV, using Odyssey for scan.
Statistical analysis
SPSS 13.0 statistics software was used. Measurement data was analyzed with mean 依 SD, t test was carried out for groups comparation. P < 0.05 was regarded as having statistical significance.
Results
General and histological observation
Normal lung's appearance was pink, without obvious abnormal change. After LPS injection, lungs became dark red, volume and weight increased, with flake bleeding points in the visceral pleura, also with serious changes, like yellow or pale red liquid overflow. By light microscopy, alveolar structure in control group was clear and complete, without edema, inflammation pathological changes in alveolar, pulmonary interstitial, pulmonary vascular and bronchial ( Figure 1 ). After LPS injection, alveolar lumen narrowed, alveolar wall blood capillary dilated, pulmonary interstitial inflammatory cell infiltrated, alveolar wall thickened, with pulmonary interstitial congestion and a small amount of bleeding in part of the alveolar cavity, as well as micro thrombus and formation of transparent membrane (Figure 2) . HE staining showed that in sevoflurane group, alveolar lumen narrowed, alveolar wall thickened, but the lesions were significantly lighter than LPS group (Figure 3) . Figure 4 and Table 1 shows that mRNA of TNF alpha and ICAM1 in LPS group was significantly higher than that of the control group (P<0.05), and mRNA of TNF alpha and ICAM1 in sevoflurane group was significantly lower than LPS group (P<0.05). Figure 5 and Table 2 shows that protein banding imprinting of TNF alpha and ICAM1 in LPS treatment group was significantly higher than that of the control group and sevoflurane group (P<0.05). lipopolysaccharide, can stimulate a variety of inflammatory medium to release. LPS can activate macrophages to release inflammatory medium, chemotaxis and arrest of neutrophils in the lungs, triggering local inflammatory reaction and produce lung injury, LPS itself also have direct damage effect to lung epithelial and vascular endothelial, with the exact ALI model [8] .
RT-PCR results
Westernblot results
Discussion
Neutrophils gathered together in the alveoli in LPS rats, is early signal of pneumonia disease reaction. In the lungs and/or blood circulation, inflammatory factors such as TNF alpha and ICAM1 stimulate the polymorphonuclear leukocyte (PMN) to be seizured in pulmonary capillaries, then adhesive in endothelial and exit the pulmonary vascular bed with continuous activation, producing a large amount of cytokines, oxygen free radicals, hydrolytic enzyme and so on, causing diffuse alveolar damage, and ultimately lead to ALI. Migration of PMN from pulmonary vascular to the lung is a complicated process, involving adhesion molecules and chemokines [9] , inhibit any link of process may affect PMN gathering. TNF alpha generated by the monocyte/macrophage during the first release of cytokines, is an important inflammation initialtion factor [10] . It can also increase cell adhesion molecule, and finally make inflammation cells to infiltrate through the tissue, then induce cell apoptosis.
Sevoflurane is a common clinical inhalation anesthetics, pure use of sevoflurane inhalation has no effect to lung organization, but it can improve the endotoxin in lung injury. Research shows that seven halothane can relieve expression of TNF alpha in acute lung injury induced byendotoxin, mainly through reducing the release of some cell factor and chemical factor from alveolar macrophages [11] . Suter et al found that sevoflurane can reduce the lung tissue edema and inflammatory cell infiltration induced by endotoxin [12] . Voigtsberger et al [13] and Yue et al [14] respectively found that sevoflurane inhibited inflammatory reaction induced by LPS in acute lung injury. But the mechanism is still not clear, it may be through a variety of signaling pathways, such as PKC, myosin and phosphorylation and mitogen activated protein kinase MAPK pathway, working on the target point of pulmonary vascular endothelial cells and epithelial cell, and ultimately improve the lung tissue permeability, its specific regulatory mechanism needs to be further in-depth study. This research shows that pneumonia disease reaction in sevoflurane treatment group was significantly lower than the LPS group, indicating sevoflurane has certain inhibition to pneumonia disease reaction. But compared with the control group, there are still certain increases, indicating that sevoflurane can decrease the inflammatory cytokines release to certain degree, but still need to coordinate with other support treatments to fully improve lung function change.
